GENTILINI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 2.469
EU - Europa 2.090
AS - Asia 284
AF - Africa 7
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.853
Nazione #
US - Stati Uniti d'America 2.463
PL - Polonia 872
RU - Federazione Russa 532
SE - Svezia 167
IE - Irlanda 150
IT - Italia 142
SG - Singapore 96
HK - Hong Kong 85
UA - Ucraina 84
DE - Germania 53
CN - Cina 52
FI - Finlandia 32
GB - Regno Unito 30
VN - Vietnam 18
JO - Giordania 16
IN - India 13
BE - Belgio 8
CA - Canada 6
ES - Italia 6
NL - Olanda 5
CH - Svizzera 4
CI - Costa d'Avorio 4
FR - Francia 4
SC - Seychelles 3
TR - Turchia 2
BD - Bangladesh 1
BR - Brasile 1
CO - Colombia 1
EU - Europa 1
LT - Lituania 1
UZ - Uzbekistan 1
Totale 4.853
Città #
Warsaw 872
Santa Clara 686
Fairfield 241
Chandler 194
Dublin 150
Jacksonville 133
Ashburn 126
Woodbridge 123
Cambridge 104
Seattle 101
Houston 98
Wilmington 90
Singapore 82
Ann Arbor 64
Hong Kong 56
Altamura 41
Florence 40
Lawrence 38
Princeton 37
Boardman 27
Boston 22
Medford 22
Moscow 22
Shanghai 20
Buffalo 19
Dong Ket 14
Kent 12
Mumbai 12
Beijing 11
San Diego 11
Brussels 8
West Jordan 8
Phoenix 7
Auburn Hills 5
Los Angeles 5
Abidjan 4
Andover 4
Barcelona 4
Castelliri 4
Frankfurt Am Main 4
Las Vegas 4
London 4
Norwalk 4
Toronto 4
Bern 3
Hillsboro 3
Milan 3
Rome 3
Dearborn 2
Helsinki 2
Lappeenranta 2
Laurel 2
Modica 2
New York 2
Ottawa 2
Redwood City 2
Salamanca 2
Silea 2
Verona 2
Berlin 1
Bogotá 1
Brentford 1
Brescia 1
Chaoyang 1
Dhaka 1
Falls Church 1
Frankfurt am Main 1
Guangzhou 1
Izmir 1
Misterbianco 1
Naaldwijk 1
Nanjing 1
Napoli 1
Pune 1
Saint Petersburg 1
Siena 1
Tappahannock 1
Tashkent 1
Torino 1
Utrecht 1
Yubileyny 1
Totale 3.593
Nome #
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells 272
Molecular pathogenesis of NASH 271
Evaluation of intracellular signalling pathways in response to insulin-like growth factor I in apoptotic-resistant activated human hepatic stellate cells. 262
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. 261
Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells 249
The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx 236
The protein kinase CK2 contributes to the malignant phenotype of cholangiocarcinoma cells 169
The role of stroma in cholangiocarcinoma: The intriguing interplay between fibroblastic component, immune cell subsets and tumor epithelium 147
Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. 139
4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. 135
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells 128
Multifaceted Aspects of Metabolic Plasticity in Human Cholangiocarcinoma: An Overview of Current Perspectives 126
EFFECTS OF NITRIC OXIDE (NO)-DONORS ON ACTIVATED HUMAN HEPATIC STELLATE CELLS (HSC): CELLULAR BASIS FOR THE TREATMENT OF PORTAL HYPERTENSION. 124
Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma. 123
Ascites and hepatorenal syndrome 120
Functional renal alterations in chronic liver diseases. 117
Characterization and regulation of insulin-like growth factor binding proteins in human hepatic stellate cells 114
Extracellular signal-regulated kinase 5 regulates the malignant phenotype of cholangiocarcinoma cells 114
The cellular and molecular basis of liver fibrogenesis. 113
Multiple biological effects of endothelin-1 in fat-storing cells isolated from human liver. 111
Fibrogenesi epatica: valutazione dell'espressione genica di citochine fibrogeniche e dei tipi più rappresentanti di collagene. 110
Novel Aspects in the Pathogenesis of Nonalcoholic Steatohepatitis. 109
Role of chemokines in the biology of cholangiocarcinoma 108
PI-3-kinase and MAPK regulate mesangial cell proliferation and migration in response to PDGF 102
Transforming growth factor beta1 regulates platelet derived growth factor receptor beta subunit in human liver fat storing cells 95
IGF-I IS A SURVIVAL FACTOR FOR HUMAN HEPATIC STELLATE CELLS (HSC): INVOLVEMENT OF PI 3-K AND C-AKT 95
Lipid perodixation increases procollagen alpha 1 (I) gene expression and synthesis in human liver fat storing cells. 94
Cellular and molecular mechanisms underlying liver fibrosis regression 90
Phosphatidylinositol 3-kinase is required for platelet-derived growth factor-dependent proliferation and chemotaxis of hepatic stellate cells 89
Endothelin-1 is overexpressed in cirrhotic liver and exerts multiple effects on activated human hepatic stellate cells. 89
Update on ascites and hepatorenal syndrome 88
Phosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-I in human hepatic stellate cells. 86
Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis 84
Purification, kinetic properties and primary structure of bovine erythrocyte acylphosphatase 73
Platelet-derived growth factor induces an increase in intracellular calcium concentration in individual human liver fat-storing cells. 71
Oncostatin M: From Intracellular Signaling to Therapeutic Targets in Liver Cancer 64
Oxidative Stress and Redox-Dependent Pathways in Cholangiocarcinoma 58
Cholangiocarcinoma tumor microenvironment highlighting fibrosis and matrix components 50
Totale 4.886
Categoria #
all - tutte 11.607
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.607


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020474 0 0 0 0 0 94 79 102 70 46 69 14
2020/2021596 48 49 66 77 25 62 24 47 50 75 25 48
2021/2022262 17 20 15 11 6 9 9 15 16 15 67 62
2022/2023731 63 148 35 61 59 123 94 51 72 4 13 8
2023/2024237 9 26 37 13 7 19 14 63 9 15 17 8
2024/20251.444 65 179 99 306 581 214 0 0 0 0 0 0
Totale 4.886